New Biomarkers Evaluating Ovarian Cancer
| Status: | Completed |
|---|---|
| Conditions: | Ovarian Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 5/5/2014 |
| Start Date: | December 2011 |
| End Date: | February 2016 |
| Contact: | Katherine L Falcone |
| Email: | falconek@fdi.com |
| Phone: | 610.240.3864 |
Evaluation of New Biomarker Assays in Ovarian Cancer Patients Presenting to a Generalist With an Adnexal Mass
The purpose of this study is to evaluate new biomarkers for patients presenting to a
physician for surgery to remove a mass in their pelvis and to continue to evaluate these
types of patients using the ROMA algorithm for post-market benefits.
physician for surgery to remove a mass in their pelvis and to continue to evaluate these
types of patients using the ROMA algorithm for post-market benefits.
Inclusion Criteria:
- Female, age 18 years or older
- Adnexal mass present documented by imaging
- Scheduled to undergo surgery based on a finding of adnexal mass
- Able and willing to provide Informed Consent
Exclusion Criteria:
- Previous history of ovarian cancer
- Previous history of bilateral oophorectomy
- Currently known to be pregnant
- Unable to provide informed consent
We found this trial at
2
sites
University of Oklahoma The OU Health Sciences Center is composed of seven health-related colleges located...
Click here to add this to my saved trials
Click here to add this to my saved trials